Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Tashbib, Khan"'
Autor:
Tashbib Khan, Mitchell A. Sullivan, Jennifer H. Gunter, Thomas Kryza, Nicholas Lyons, Yaowu He, John D. Hooper
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Once thought to be exclusively a storage hub for glucose, glycogen is now known to be essential in a range of physiological processes and pathological conditions. Glycogen lies at the nexus of diverse processes that promote malignancy, including prol
Externí odkaz:
https://doaj.org/article/5ee251c7b0914f95a69662f28d0c9995
Autor:
Tashbib Khan, Thomas Kryza, Yaowu He, Jennifer H Gunter, Madeline Gough, Cameron Snell, John D. Hooper
BackgroundClear cell carcinomas (CCCs) are a distinct histopathological subtype defined by a clear cytoplasm comprised of glycogen and lipids and characterised by poor prognosis and widespread chemoresistance. In the present work we investigate glyco
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::32b18374f8b165c3c3d719dfe561ee70
https://doi.org/10.1101/2023.05.01.538916
https://doi.org/10.1101/2023.05.01.538916
Autor:
Tashbib, Khan, Nicholas J, Lyons, Madeline, Gough, Kayden K X, Kwah, Tahleesa J, Cuda, Cameron E, Snell, Brian W, Tse, Kamil A, Sokolowski, Lesley A, Pearce, Timothy E, Adams, Stephen E, Rose, Simon, Puttick, Marina, Pajic, Mark N, Adams, Yaowu, He, John D, Hooper, Thomas, Kryza
Publikováno v:
Theranostics. 12:6915-6930
The Australasian Cell Death Society (ACDS): celebrating 50 years of Australasian cell death research
Autor:
Daniel S Simpson, Amy Chan, Tahnee L. Saunders, Ivan K. H. Poon, Tashbib Khan, Georgia K. Atkin-Smith, Mary Speir
Publikováno v:
Immunology & Cell Biology. 100:9-14
Autor:
Stephen E. Rose, Chao Li, Paul Thomas, James C. Whisstock, Kamil A. Sokolowski, Simon Puttick, T. Cuda, Elena I. Deryugina, James P. Quigley, Cameron Snell, David Wyld, Ashleigh Parkin, Tashbib Khan, Ruby H. P. Law, Thomas Kryza, Marina Pajic, Andrew D. Riddell, Brian W.C. Tse, Madeline Gough, Yaowu He, John D. Hooper, Nicholas Lyons, Andrew Barbour, Julia Yin
Publikováno v:
Theranostics
Background: CUB domain-containing protein 1 (CDCP1) is a cell surface receptor regulating key signalling pathways in malignant cells. CDCP1 has been proposed as a molecular target to abrogate oncogenic signalling pathways and specifically deliver ant
Autor:
Paul J. Conroy, Kamil A. Sokolowski, Simon Puttick, S. John Weroha, Thomas Kryza, James C. Whisstock, Brittney S. Harrington, Samantha J. Stehbens, Paul Haluska, T. Cuda, Rohan Lourie, Sarah Reed, Brian W.C. Tse, Buddhika J. Arachchige, Lewis Perrin, Yaowu He, Tashbib Khan, Katherine K. Robbins, Ruby H. P. Law, Carlos Salomon, Pamela M. Pollock, John D. Hooper
Publikováno v:
Theranostics
CUB-domain containing protein 1 (CDCP1) is a cancer associated cell surface protein that amplifies pro-tumorigenic signalling by other receptors including EGFR and HER2. Its potential as a cancer target is supported by studies showing that anti-CDCP1
Autor:
Kamil A. Sokolowski, Simon Puttick, Cheng Liu, Madeline Gough, Brian W.C. Tse, T. Cuda, Yaowu He, Andrew R. L. Stevenson, Stephen E. Rose, Andrew D. Riddell, Cameron Snell, David A. Clark, Nicholas Lyons, Paul Thomas, Tashbib Khan, David Wyld, Thomas Kryza, John D. Hooper
Publikováno v:
Contrast Media & Molecular Imaging
Contrast Media & Molecular Imaging, Vol 2021 (2021)
Contrast Media & Molecular Imaging, Vol 2021 (2021)
Colorectal cancer (CRC) is the third most common malignancy in the world, with 22% of patients presenting with metastatic disease and a further 50% destined to develop metastasis. Molecular imaging uses antigen-specific ligands conjugated to radionuc
Autor:
Charlotte C. Williams, Simon Puttick, Nicholas Lyons, Lesley A. Pearce, Lewis Perrin, Thomas Hodgkinson, Tashbib Khan, Trent P. Munro, Sinead Barry, Michael D. Lee, Timothy E. Adams, C. Blake Gilks, Thomas Kryza, Rohan Lourie, Claire M. Davies, Yaowu He, Madeline Gough, John D. Hooper, Justin B. Goh, Martina L. Jones, Rebecca Rogers, Naven Chetty
Publikováno v:
Molecular pharmaceutics. 18(9)
Optimal cytoreduction for ovarian cancer is often challenging because of aggressive tumor biology and advanced stage. It is a critical issue since the extent of residual disease after surgery is the key predictor of ovarian cancer patient survival. F
Autor:
Rabina Giri, Robert Gordon, Graham W. Magor, Yaowu He, Thomas Kryza, Tashbib Khan, Veronika Schreiber, Sumaira Z. Hasnain, Adam Ewing, John Hooper, Timothy H. Florin, Andrew Perkins, Manish Gala, Jakob Begun
Publikováno v:
Gastroenterology. 162:S-17